Lv3
328 积分 2022-11-29 加入
Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer
14天前
已完结
Cancer burden and control in China: landscape, trends and challenges
1个月前
已完结
Research progress of targeted BCMA CAR-T therapy for relapsed/refractory multiple myeloma antigen-negative relapse
1个月前
已完结
Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologists
1个月前
已完结
Preclinical application of a CD155 targeting chimeric antigen receptor T cell therapy for digestive system cancers
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
4个月前
已完结
CD155 and its receptors in cancer immune escape and immunotherapy
6个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
8个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
8个月前
已完结
Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses
8个月前
已完结
皖公网安备34019202002308
